2,163
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma

, , , ORCID Icon &
Article: e1392427 | Received 16 Aug 2017, Accepted 11 Oct 2017, Published online: 06 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Zhen Xiang, Wei Chen, Jun Zhang, Shuzheng Song, Guang-Kai Xia, Xin-Yu Huang, Juan Xie, Yingyan Yu & Qing-Yuan Zhang. (2019) Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer. Immunopharmacology and Immunotoxicology 41:3, pages 386-393.
Read now

Articles from other publishers (25)

Guiquan Zhu, Fan Yang, Hongxuan Wei, Wanrong Meng, Jianguo Gan, Linlin Wang, Chuanshi He, Shun Lu, Bangrong Cao, Huaichao Luo, Bo Han & Ling Li. (2023) 90 K increased delivery efficiency of extracellular vesicles through mediating internalization. Journal of Controlled Release 353, pages 930-942.
Crossref
Jingwen Liu, Fei YuZhao LiuXiaojing WangJianming Li. (2022) A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals 37:10, pages 963-975.
Crossref
Na Wang, Dan-Ni He, Zhe-Yu Wu, Xu Zhu, Xiao-Ling Wen, Xu-Hua Li, Yu Guo, Hong-Jiu Wang & Zhen-Zhen Wang. (2022) Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer. Frontiers in Genetics 13.
Crossref
Chun Chen, Yifei Zhang, Yupeng Liu, Lei Hang & Jun Yang. (2022) Expression of Tumor Suppressor SFRP1 Predicts Biological Behaviors and Prognosis: A Potential Target for Oral Squamous Cell Carcinoma. Biomolecules 12:8, pages 1034.
Crossref
Elena Muraro, Rebecca Romanò, Giuseppe Fanetti, Emanuela Vaccher, Irene Turturici, Valentina Lupato, Fabio Biagio La Torre, Jerry Polesel, Elisabetta Fratta, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Michele Spina & Salvatore Alfieri. (2022) Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology. Critical Reviews in Oncology/Hematology 175, pages 103707.
Crossref
Yuhong Huang, Han Liu, Xuena Liu, Nan Li, Han Bai, Chenyang Guo, Tian Xu, Lei Zhu, Chao Liu & Jing Xiao. (2022) The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC. Frontiers in Genetics 13.
Crossref
Xing Zeng, Le Li, Zhiquan Hu & Dan Peng. (2022) Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC). Frontiers in Oncology 12.
Crossref
JIAYU ZHANG, RUOYAN CAO, JIANMIN PENG, QINCHAO HU, JUAN XIA & BIN CHENG. (2022) In Silico analysis and linking of metabolism-related genes with the immune landscape in head and neck squamous cell carcinoma. BIOCELL 46:1, pages 111-125.
Crossref
Hua Zhong, Shuai Liu, Fang Cao, Yi Zhao, Jianguo Zhou, Feng Tang, Zhaohua Peng, Yangsheng Li, Shen Xu, Chunlin Wang, Guohua Yang & Zhi-Qiang Li. (2021) Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine. Frontiers in Immunology 12.
Crossref
Bohai Feng & Jochen Hess. (2021) Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer. Cancers 13:5, pages 1162.
Crossref
Mara S. Serafini, Laura Lopez-Perez, Giuseppe Fico, Lisa Licitra, Loris De Cecco & Carlo Resteghini. (2020) Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures. Cancers of the Head & Neck 5:1.
Crossref
Zihao Wang, Xiaopeng Guo, Lu Gao, Kan Deng, Wei Lian, Xinjie Bao, Ming Feng, Lian Duan, Huijuan Zhu & Bing Xing. (2020) The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness. The Journal of Clinical Endocrinology & Metabolism 105:9, pages e3207-e3223.
Crossref
Denggang Fu, Biyu Zhang, Lei Yang, Shaoxin Huang & Wang Xin. (2020) Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma. Frontiers in Genetics 11.
Crossref
HongLei Wang, Li Wu & HongTao Wang. (2020) Development and verification of a personalized immune prognostic feature in breast cancer. Experimental Biology and Medicine 245:14, pages 1242-1253.
Crossref
Bohai Feng, Ying Shen, Xavier Pastor Hostench, Matthias Bieg, Michaela Plath, Naveed Ishaque, Roland Eils, Kolja Freier, Wilko Weichert, Karim Zaoui & Jochen Hess. (2020) Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer. Clinical Cancer Research 26:14, pages 3616-3628.
Crossref
Sungjae Kim, Ahreum Kim, Jong-Yeon Shin & Jeong-Sun Seo. (2020) The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types. Scientific Reports 10:1.
Crossref
Rosemarie Krupar, Christian Watermann, Christian Idel, Julika Ribbat-Idel, Anne Offermann, Helen Pasternack, Jutta Kirfel, Andrew G. Sikora & Sven Perner. (2020) In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation. Scientific Reports 10:1.
Crossref
Mingjun Zheng, Yuexin Hu, Rui Gou, Ouxuan Liu, Xin Nie, Xiao Li, Qing Liu, Yingying Hao, Juanjuan Liu & Bei Lin. (2020) Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma. Journal of Cellular and Molecular Medicine 24:5, pages 2819-2831.
Crossref
Bin Liang, Ye Tao & Tianjiao Wang. (2020) Profiles of immune cell infiltration in head and neck squamous carcinoma. Bioscience Reports 40:2.
Crossref
Yuehua Ma, Shundong Cang, Guoqing Li, Yong Su, Huifeng Zhang, Limin Wang, Junpeng Yang, Xiaoyang Shi, Guijun Qin & Huijuan Yuan. (2019) Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression. Journal of Cellular Physiology 234:12, pages 22260-22271.
Crossref
Wenli Li, Huimei Wang, Zhanzhong Ma, Jian Zhang, Wen Ou-yang, Yan Qi & Jun Liu. (2019) Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma. Frontiers in Oncology 9.
Crossref
Bangrong Cao, Wei Dai, Shiqi Ma, Qifeng Wang, Mei Lan, Huaichao Luo, Tingqing Chen, Xiaojun Yang, Guiquan Zhu, Qiang Li & Jinyi Lang. (2019) An EV-Associated Gene Signature Correlates with Hypoxic Microenvironment and Predicts Recurrence in Lung Adenocarcinoma. Molecular Therapy - Nucleic Acids 17, pages 879-890.
Crossref
Jeong-Sun Seo, Ahreum Kim, Jong-Yeon Shin & Young Tae Kim. (2018) Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor. Scientific Reports 8:1.
Crossref
Chenxia Juan, Yan Mao, Qian Wang, Qian Cao, Yan Chen & Guoping Zhou. (2018) The LncRNA MALAT1 regulates CD80 transcription via the NF-κB signaling pathway in the A549 cell line. Biochemical and Biophysical Research Communications 503:3, pages 1674-1681.
Crossref
Jin Chen, Guiming Fu, Yibo Chen, Guiquan Zhu & Zhaohui Wang. (2018) Gene‑expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma. Oncology Letters.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.